A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC

J Thorac Dis. 2017 Mar;9(3):E292-E294. doi: 10.21037/jtd.2017.02.86.

Authors

Petros Christopoulos^{1

2}, Michael Thomas^{1

2}

Affiliations

¹ Department of Thoracic Oncology, Thoraxklinik at the Heidelberg University Medical Center, Heidelberg, Germany.
² Translational Lung Research Center Heidelberg (TLRC-H), The German Center for Lung Research (DZL), Heidelberg, Germany.

No abstract available

Publication types

Editorial
Comment